So, it can be speculated that the relative amount between PGE2 and PGA2 in tumor microenvironment may contribute to the determination of the efficacy of both anti-cancer chemotherapy and radiotherapy, the effect of which is dependent on p53 activity. This evidence concerns the gene TP53 and cancer.